RESEARCH: Study by researchers at Imperial College London found people who've had coronavirus were 'more likely to have increased levels of biomarkers linked to faulty amyloid proteins – a known hallmark for Alzheimer’s disease' and that effects were 'comparable to four years of ageing with the greatest effects seen in those hospitalised with severe COVID-19 or with underlying risk factors'

Published by The Spectator Index